Susquehanna Fundamental Investments, LLC Agios Pharmaceuticals, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$33.21 - $46.54 $753,867 - $1.06 Million	-22,700 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$33.87 - $55.93 $237,089 - $391,510	7,000 Added 44.59%	22,700 $795,000
Q2 2020 Aug 14, 2020	BUY	$34.45 - $53.48 $540,865 - $839,636	15,700 New	15,700 $840,000

226

56.2M

275K

251K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $2.83B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.